The performance of companies tied to iconic drugs like Viagra presents a challenging investment landscape . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial returns, the patent expiration in key territories has introduced substantial uncertainty . Investors are now facing the impact of lower-co